Disease | renal cell carcinoma |
Symptom | C0032227|pleural effusion |
Sentences | 1 |
PubMedID- 23328294 | Objective: to evaluate the safety and efficacy of sorafenib plus cisplatin in the treatment of metastatic renal cell carcinoma (mrcc) with pleural effusion. |
Page: 1